Skip to content
Screener

Evolent Health, Inc. EVH Reportable segment — Interest Income

Similar metrics at other companies

Veradermics logo
MANEReportable Segment — Interest Income
$2.5M+400%
Bicara Therapeutics logo
BCAXReportable Segment — Interest Income
$4.08M-18.6%
nCino, Inc. logo
NCNOReportable Segment — Interest Income
$366K-12.2%
DocuSign logo
DOCUReportable Segment — Interest Income
$8.73M-18.4%
UiPath logo
PATHReportable Segment — Interest Income
$10.4M-17.8%
YSS
YSSReportable Segment — Interest Income
$4.62M+754%

Other financials

Income statement

See full
Revenue$652.5M+46.9%
Gross profit$80.8M-19.5%
Operating income-$9.6M-716%
Net income-$28.4M-42.6%
EPS (diluted)-$0.25+43.2%

Balance sheet

See full
Cash & equivalents$115.7M-23.4%
Total debt$970.4M+13.7%
Total equity$383.2M-57.2%
Total assets$2.0B-19.9%

Cash flow

See full
Operating cash flow-$9.3M+69.3%

Valuation

See full
Market cap$446.58M-58.4%
Enterprise value$1.3B-26.7%
P/S0.2×-0.3×

Profitability

See full
Gross margin17.2%+0.9pp
Operating margin-20.4%-22.4pp
Net margin-24.1%-35.8pp
FCF margin-9.7%

Returns & leverage

See full
Return on equity-79%-99.2pp
Debt / equity2.5×+1.6×
Current ratio1.2×+0.2×

Where this comes from

Reported directly by Evolent Health, Inc. in its filing.

Tagged under the XBRL concept us-gaap:InvestmentIncomeInterest.

The source filing: Evolent Health, Inc.’s 10-Q, filed August 6, 2026.

Filed
Aug 6, 2026, 8:53 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001628908-26-000086
Line itemFor the Three Months Ended June 30, 2026For the Three Months Ended June 30, 2025For the Six Months Ended June 30, 2026For the Six Months Ended June 30, 2025
Cost of revenue excluding medical expense and device costs and other segment items (2)77,96693,732154,557181,576
Selling, general and administrative expenses excluding other segment items (3)53,48163,888115,707130,156
Depreciation and amortization expenses21,56623,14143,12147,199
Interest income(703)(1,084)(1,717)(2,358)
Interest expense16,85911,60133,72721,986
Gain (loss) from equity method investees41(197)52(178)
Provision for (benefit from) income taxes2,715(825)3,625645
Other segment items (4)15,93656,00126,305130,453

Item 1. Financial Statements

FAQ

What is Evolent Health, Inc.'s reportable segment — interest income?
Evolent Health, Inc. (EVH) reported reportable segment — interest income of $703K in Q2 2026.
How has Evolent Health, Inc.'s reportable segment — interest income changed year-over-year?
Evolent Health, Inc.'s reportable segment — interest income decreased by 35.1% year-over-year, from $1.08M to $703K.
What is the long-term trend for Evolent Health, Inc.'s reportable segment — interest income?
Over 3 years (2022 to 2025), Evolent Health, Inc.'s reportable segment — interest income has grown at a 45.2% compound annual growth rate (CAGR), from $1.37M to $4.19M.
What does reportable segment — interest income mean?
This represents the income generated from cash balances or financial investments held by the segment. It serves as a minor indicator of the segment's liquidity management and treasury activities.

Ask your AI about Evolent Health, Inc.'s reportable segment — interest income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude